Niagen Bioscience Inc (NAGE) vs Whitehawk Therapeutics Inc (WHWK)
A side-by-side comparison of Niagen Bioscience Inc and Whitehawk Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NAGE
Niagen Bioscience Inc
$2.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WHWK
Whitehawk Therapeutics Inc
$3.61HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NAGE vs WHWK
growth of $100 · dividends reinvested · last 9yNAGE -16.2% (-2.0%/yr)WHWK -95.9% (-29.9%/yr)NAGE compounded faster over this window
Log scale — wide-divergence pair
NAGE WHWK
NAGE vs WHWK: by the numbers
- •NAGE is the larger company ($214M vs $206M market cap).
- •NAGE is profitable (12.39% net margin) while WHWK runs a net loss (-288.26%).
Metrics side by side
Valuation
| Metric | NAGE | WHWK |
|---|---|---|
| P/E ratio | 14.43 | N/A |
| Forward P/E | 18.65 | N/A |
| P/S ratio | 1.66 | N/A |
| P/B ratio | 2.60 | 1.13 |
| EV / EBITDA | 14.36 | N/A |
| FCF yield | 2.65% | N/A |
Profitability
| Metric | NAGE | WHWK |
|---|---|---|
| Gross margin | 64.24% | 89.36% |
| Operating margin | 6.67% | -1601.12% |
| Net margin | 12.39% | -288.26% |
| ROE | 19.38% | -43.64% |
| ROIC | 8.84% | -47.05% |
Growth (annualized)
| Metric | NAGE | WHWK |
|---|---|---|
| Revenue CAGR (5Y) | 15.80% | N/A |
| Total return CAGR (5Y) | -15.72% | -33.13% |
Frequently asked
- Is NAGE or WHWK more profitable?
- NAGE runs the higher net margin — NAGE at 12.39% versus WHWK at -288.26%.
- How have NAGE and WHWK total returns compared?
- Over the past 5 years, NAGE delivered -15.72% and WHWK delivered -33.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Niagen Bioscience P/E ratioNiagen Bioscience ROEWhitehawk Therapeutics ROENiagen Bioscience operating marginWhitehawk Therapeutics operating marginNiagen Bioscience revenue growthWhitehawk Therapeutics revenue growthNiagen Bioscience free cash flowWhitehawk Therapeutics free cash flow
Niagen Bioscience & Whitehawk Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.